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CXC chemokines generate age-related increases in neutrophil-
mediated brain inflammation and blood–brain barrier breakdown 
Daniel Anthony*, Robert Dempster*, Sara Fearn*, John Clements†, 
Graham Wells†, V. Hugh Perry* and Katharine Walker*‡
Children are at greater risk than adults of permanent
brain damage and mortality following head injury or
infection [1–5]. Rodent models have demonstrated a
‘window of susceptibility’ in young animals during which
the brain parenchyma is at greater risk of acute
neutrophil-mediated breakdown of the blood–brain
barrier [6,7]. The exact mechanism of this age-related
susceptibility to brain inflammation has yet to be
defined, but animal models have revealed that the
potent pro-inflammatory cytokine interleukin-1b (IL-1b)
initiates an intense acute neutrophil-mediated
inflammatory response in the brains of young rats and
mice that is not seen in adults [6]. Here, we demonstrate
the rapid induction of CXC chemokines (which contain a
Cys–X–Cys motif), in particular the cytokine-induced
neutrophil chemoattractant CINC-1, following the intra-
cerebral administration of IL-1b. The CXC chemokines
produced a more intense neutrophil response in young
rats than in adults. The IL-1b-induced blood–brain
barrier breakdown in young rats could be attenuated by
an anti-CINC-1 neutralising antibody. These results
show that the immature central nervous system (CNS) is
dramatically more susceptible to the chemotactic effects
of CXC chemokines. Blocking the CXC chemokine
activity associated with brain inflammation inhibits
neutrophil-mediated blood–brain barrier damage and
represents a significant therapeutic possibility.
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Results and discussion
The early expression of CXC chemokines that induce neu-
trophil chemotaxis was examined in adult and juvenile rat
brain to see whether these chemokines might underlie the
acute pro-inflammatory effects of IL-1β. A competitive
reverse transcriptase (RT)–PCR assay [8] was used to
determine the level of acute mRNA expression for the rat
CXC chemokines CINC-1 and macrophage inhibitory
protein-2 (MIP-2) following intra-cerebral administration
of rat recombinant (rr) IL-1β [9,10]. After extracting
mRNA, the cDNA was reverse transcribed from it and
amplified by PCR in the presence of known concentrations
of a synthetic standard plasmid containing primer sites for
rat β-actin, CINC-1 and MIP-2 that yielded products dis-
tinguishable by size from the PCR products copied from
the reverse-transcribed mRNA (see Supplementary mater-
ial, published with this paper on the internet). The assay
revealed a rapid increase in both MIP-2 and CINC-1
mRNAs in the groups of rats treated with IL-1β, whereas
these mRNAs were virtually undetectable in saline-treated
controls (Figure 1a). CINC-1 mRNA, in particular, showed
a 10,000-fold increase in expression in IL-1β-treated brain.
Using a rat CINC-1 enzyme-linked immunosorbent assay
(ELISA) we found that CINC-1-like immunoreactivity
was also increased in adult and juvenile rats 4 hours follow-
ing IL-1β administration (Figure 1b).
Despite previous demonstrations of more intense IL-1β-
induced neutrophil recruitment and blood–brain barrier
breakdown in juvenile rats [6], the experiments described
above indicate that the expression of CXC chemokines,
particularly CINC-1, occurs rapidly and to much the same
level in the brains of adults and juveniles. We therefore
examined whether, like IL-1β, the intra-cerebral adminis-
tration of CXC chemokines would precipitate a different
pattern of responses in adult and juvenile brains. Striking
age-related differences were observed in the effects of
both rrCINC-1 and rrMIP-2 (Figure 2). Whereas in
control rats the microinjection of vehicle produced no
neutrophil recruitment or blood–brain barrier breakdown
measured as horseradish peroxidase (HRP) extravasation,
microinjection of CINC-1 induced profound HRP
extravasation and neutrophil recruitment as early as
4 hours following its administration to juvenile rat brain
(Figures 2a,3a,3c). Adult rats showed significantly less
neutrophil recruitment and HRP extravasation at the
4 hour time-point (Figures 2b,3a,3c). CINC-1-induced
neutrophil recruitment was observed in adult rats, particu-
larly at 12 hours after CINC-1 administration (Figure 3a);
the overall neutrophil response was lower and delayed
(analysis of variance, p < 0.05), however, compared with
juveniles. HRP extravasation following CINC-1 adminis-
tration was rapid and extensive in juveniles, showing a
gradual decline over 24 hours (Figure 3c). In adults,
however, HRP extravasation was almost absent at the
early time-points and never reached the maximal
response displayed in juvenile brain (Figure 3c). MIP-2
also induced a more intense response in juvenile rats than
in adults, although in comparison with CINC-1 the onset
of neutrophil recruitment and HRP extravasation induced
by MIP-2 was delayed (Figures 2c,3b,3c). In contrast to
the rapid and widespread effects of CINC-1, MIP-2
induced intense, but focal, neutrophil recruitment to the
striatum from 12 to 24 hours following its administration
(Figure 3b). MIP-2 induced less HRP extravasation than
CINC-1 (Figure 3c). In keeping with the putative neu-
trophil-selective chemotactic effects of these CXC
chemokines, almost all the leukocytes that were recruited
within the 24 hours following the administration of
CINC-1 and MIP-2 were neutrophils (Figure 3a,b). The
HRP extravasation induced by both CINC-1 and MIP-2
was also neutrophil-dependent, because it was inhibited
following the depletion of circulating neutrophils with an
anti-neutrophil antiserum (Figure 2d).
Given these results, we decided to test whether the
intense inflammatory response and blood–brain barrier
breakdown induced by IL-1β in juvenile rats could be
attenuated by the administration of an anti-rat CINC-1
neutralising antibody. Juvenile rats treated with IL-1β
plus a control non-specific rabbit immunoglobulin G
(IgG) displayed a brain inflammatory response 4 hours
following treatment that was comparable to that previ-
ously described for IL-1β [6] (Figures 2e,4). The IL-1β-
treated brains showed extensive blood–brain barrier
breakdown with concomitant intraparenchymal neu-
trophil recruitment. Injection of the non-specific rabbit
IgG or the anti-CINC-1 neutralising antibody alone did
not produce an inflammatory response (Figure 4a). In
marked contrast, animals treated with IL-1β plus the
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Figure 1
Microinjection of rrIL-1β (1 ng) into adult or
juvenile rat striatum induces expression of
CXC chemokines. (a) Quantitation of rat
CINC-1 and MIP-2 mRNA (measured via
quantitation of cDNA) in rat striatum 4 h
following the injection of rrIL-1β or saline. The
ratio of standard cDNA to cellular cDNA was
plotted on a log–log scale against the dilution
of standard. The dilution value when the ratio
of standard to cellular cDNA was equal to 1
was calculated [8]. Log mean ± SEM (n = 3
rats per group) cDNA levels are expressed as
a percentage of β-actin cDNA levels for each
sample. An asterisk denotes a significant
difference (p < 0.01) between the IL-1-treated
and saline-treated groups. (b) Expression of
rat CINC-1-like immunoreactivity 4 h following
IL-1β or saline administration to adult and
juvenile rat striatum (mean ± SEM; n = 4 rats
per group). An ELISA (rat CINC-1 ELISA kit,
IBL [11]) of each sample was carried out in
triplicate and quantitation of CINC-1-like
immunoreactivity was determined using a
standard curve of rrCINC-1.
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Figure 2
Blood–brain barrier breakdown induced by CXC chemokines in adult
and juvenile rat brain measured by HRP extravasation. (a) Juvenile 
(3-week-old) and (b) adult (3-month-old) rat brains 4 h following an
intra-striatal injection of 0.5 µg rrCINC-1 (n = 3 rats per group). The
extent of HRP extravasation in juvenile rat brain 12 h following CINC-1
administration was similar to that at 4 h (see Figure 3c). (c) Juvenile rat
brain 12 h following an intra-striatal injection of 0.5 µg rrMIP-2.
(d) Inhibition of CINC-1-induced (0.5 µg) HRP extravasation in juvenile
rat brain by depletion of circulating neutrophils following systemic
administration of a rat neutrophil-depleting antiserum. (e) HRP
extravasation in juvenile rat brain 4 h following intra-striatal injection of
rrIL-1β (1 ng) plus control IgG (1 µg). (f) This IL-1β-induced HRP
extravasation was inhibited by co-administration of rrIL-1β plus an anti-
CINC-1 neutralising antibody (1µg).
anti-CINC-1 neutralising antibody showed a significant
reduction in neutrophil recruitment and almost complete
absence of HRP extravasation (Figures 2f,4).
These results demonstrate that the intense neutrophil
recruitment and concomitant blood–brain barrier break-
down induced by IL-1β in the brains of juvenile rats is
largely accounted for by an increased susceptibility to the
neutrophil chemotactic effects of CXC chemokines. An
anti-rat CINC-1 neutralising antibody significantly inhib-
ited both neutrophil recruitment to the juvenile brain
parenchyma and IL-1β-induced HRP extravasation. The
latter finding is consistent with the previous demonstra-
tion that IL-1β-induced HRP extravasation in juvenile
rats is neutrophil dependent [6]. Yamasaki et al. [11] have
also demonstrated that systemic administration of an anti-
CINC-1 neutralising antibody can reduce increases in
brain water content following ischemic reperfusion injury
in adult rats. The increased neutralising effect of the anti-
CINC-1 antibody seen in this study compared with that of
Yamasaki et al. [11] is likely to be due to IL-1β-induced
chemokine synthesis and presentation by CNS cells, such
as astrocytes [12].
The induction of cytokines by CNS cells has been
reported in conjunction with many different neuropatholo-
gies [13,14]. Nevertheless, experiments in rats and mice
have shown that IL-1β-induced leukocyte recruitment and
plasma extravasation in the adult brain parenchyma is
slower and attenuated compared with that seen in periph-
eral tissues [15]. This inherent resistance to brain inflam-
mation offers a direct advantage to the host in terms of
protecting neural tissue from permanent damage. Compar-
ison of the dose–response relationships for IL-1β-induced
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Inflammation and blood–brain barrier breakdown induced by CXC
chemokines in adult and juvenile rat brain. Leukocyte recruitment to
adult and juvenile striatum, measured at the intervals shown, following
an injection of (a) rrCINC-1 (0.5 µg) or (b) rrMIP-2 (0.5 µg).
Polymorphonuclear neutrophils were identified using a rat polyclonal
anti-neutrophil antibody (ANS) [18]. Macrophages were identified
using the monoclonal antibody ED1 (donated by the Dunn School of
Pathology). (c) HRP extravasation in adult and juvenile brain 4 h
following an injection of rrCINC-1 (0.5 µg) or rrMIP-2 (0.5 µg). An
asterisk denotes a significant difference between the respective adult
and juvenile groups (mean ± SEM; n = 3 rats per group; t test, p < 0.05).
Figure 4
Inhibitory effects of an anti-CINC-1
neutralising antibody on inflammation and
blood–brain barrier breakdown in juvenile rats.
(a) Neutrophil recruitment to juvenile brain
parenchyma 4 h following co-administration of
either rrIL-1β (1 ng) plus control IgG (1 µg;
positive control), rrIL-1β plus anti-CINC-1
neutralising antibody (1 µg), or anti-CINC-1
neutralising antibody (1 µg) alone
(mean ± SEM; n = 4 rats per group). Because
polyclonal antibodies had already been
administered, neutrophils were identified
using the monoclonal antibodies OX1 and
OX30 (combined in a 1:1 ratio; donated by
the Dunn School of Pathology) against
leukocyte common antigen (LCA) and by their
characteristic polylobar nuclei. (b) HRP
extravasation in the brains of the same animals
shown in (a). An asterisk denotes a significant
difference between the indicated bars,
p < 0.01 (mean ± SEM; n = 4 rats per group).
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inflammation in the brains of young and adult rats,
however, indicates that the brains of young rats are more
susceptible to the inflammatory effects of IL-1β [6,7].
Neither the postnatal development of the blood–brain
barrier nor the differential expression of adhesion mole-
cules mediate these age-related differences [6,7,16]. The
inhibition of blood–brain barrier breakdown by the deple-
tion of circulating neutrophils or by an anti-CINC-1 neu-
tralising antibody clearly shows, however, that it is the
neutrophil chemotactic effects of CXC chemokines that
are most destructive to the juvenile rat brain. 
Once in the brain, neutrophils are potent contributors to
the acute inflammatory response and can promote neural
injury. This has been clearly demonstrated in transgenic
mice expressing the CXC chemokine N51/KC in brain
oligodendrocytes [17]. Neutrophil-mediated blood–brain
barrier breakdown is a mechanism by which CNS tissue
can be damaged. Neurological studies have demonstrated
that alterations in blood–brain barrier breakdown perme-
ability, and cerebral oedema in children and infants with
bacterial meningitis, are directly associated with poor
prognosis [5]. Several clinical studies have noted the
increased risk of permanent brain damage and poor prog-
nosis following head injury or cerebral infection in young
children [4,5]. Mortality rates following head injury are
much higher in children [3] and acute infections, such as
meningitis and malaria, are not only more frequent but
also more severe in young children than in adults [1,2].
Clearly, if the childhood risks associated with brain injury
and infection are due to an increased susceptibility to neu-
trophil-mediated brain inflammation then the prevention
of neutrophil recruitment to the brain by antagonising the
effects of CXC chemokines would represent a significant
therapeutic possibility.
Materials and methods
Wistar rats (Charles River) received intra-striatal microinjections
(maximum volume, 1 µl) as described [6]. Rat recombinant IL-1β
(National Institute for Biological Standards and Controls) was dis-
solved in a solution of 0.1% bovine serum albumin in PBS, or mixed
with an anti-rat CINC-1 neutralising antibody (Peprotech) or rabbit
IgG (Serotec). Rat recombinant MIP-2 and CINC-1 (Peprotech) were
freshly made up from lyophilised protein immediately before use, and
dissolved in sterile filtered 0.9% saline. Assessment of the
blood–brain barrier with type II HRP (Sigma), 104 U/kg, as a blood-
borne tracer was carried out as described [6]. Quantitation of the area
of HRP extravasation from brain sections was calculated using Optilab
2.1 for Macintosh software (Graphtec). Immunohistochemistry was
used to confirm the presence and distribution of specific cell popula-
tions [6]. For PCRs and ELISAs, rats were killed 4 h following IL-1β
administration, brains were removed and the striatums from the
injected hemisphere were dissected and quickly frozen in liquid nitro-
gen. A neutrophil-depleting antiserum (Acurate) was used to deplete
circulating neutrophils in 3-week-old rats, as described [6], and
resulted in profound neutrophil depletion.
Supplementary material
A table showing primer sequences and amplicon lengths for the com-
petitive RT–PCR assay is published with this paper on the internet.
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S1Supplementary material
Table S1
Primer sequences and amplicon lengths for the CXC chemokine competitive RT–PCR assay.
EMBL accession Forward primer Reverse primer Standard amplicon cDNA amplicon
number sequence (5′→3′) sequence (5′→3′) length (bp) length (bp)
Rat β-actin L00981 TCCTTCCGCCTATGGAATC ACTCATCGTACTCCTGCTTG 205 300
Rat CINC-1 M86536 GCTCGCTTCTCTGTGCAGC CCATCGGTGCAATCTATCTTC 204 298
Rat MIP-2 X65647 TCCTCAATGCTGTACTGGTC ATGTTCTTCCTTCCCAGGTC 201 299
